In this study, we investigated the serum levels of sFRP2 among patients in different HF stages with or without T2DM and analyzed its association with fasting blood glucose (FBG), glycated hemoglobin (HbA1c), blood lipid levels, BMI and other cardiometabolic risk factors. The gene discussed is SFRP2; the disease is hydrops fetalis.